Filtered By:
Source: International Journal of Environmental Research and Public Health
Drug: Azithromycin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
IJERPH, Vol. 18, Pages 102: Cardiovascular Comorbidities and Pharmacological Treatments of COVID-19 Patients Not Requiring Hospitalization
Conclusions: Our data show a high prevalence of hypertension, more likely treated with renin–angiotensin–aldosterone system (RASS) inhibitors, among COVID-19 patients not requiring hospitalization. Experimental COVID-19 therapies have been prescribed to COVID-19 patients considered at risk for increased venous thromboembolism based on concomitant comorbidities, in particular diabetes and hypertension.
Source: International Journal of Environmental Research and Public Health - December 25, 2020 Category: Environmental Health Authors: Russo Piccinocchi Mandaliti Annunziata Cimmino Attena Moio Di Micco Severino Trotta Del Guercio Tags: Article Source Type: research
